'Hijacker' drives cancer in some patients with high-risk neuroblastoma

Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights may help scientists develop more effective therapies, including precision medicines.

Read more: https://medicalxpress.com/news/2018-01-hijacker-cancer-patients-high-risk-neuroblastoma.html